In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
November 5th, 2008 | 29 | Yes |
Popular Name: NAFTOPIDIL NAFTOPIDIL
Find On: PubMed — Wikipedia — Google
CAS Numbers: 57149-07-2 , 57149-08-3 , 57419-08-3 , [57149-07-2]
1-[4-(2-Methoxy-phenyl)-piperazin-1-yl]-3-(naphthalen-1-yloxy)-propan-2-ol
1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-(naphthalen-1-yloxy)propan-2-ol
57149-07-2; D01674; Flivas (TN); Naftopidil (JAN/INN)
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 4.14 | 7.66 | -9.68 | 1 | 5 | 0 | 45 | 392.499 | 7 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
biological_use | Antihypertensive agent | ZereneX Building Blocks |
MP | 127 | TCI |
Target | Adrenergic Receptor | Selleck Chemicals |
mechanism | alpha-1 Adrenoceptor and calcium antagonist | IBScreen Bioactives |
Therapy | alpha1 Adrenoceptor antagonist; antihypertensive | SMDC Iconix |
Indications | antihypertensive | KeyOrganics Bioactives |
biological_use | Antihypertensive agent | IBScreen Bioactives IBScreen Bioactives |
therap | antihypertensive, alpha-blocker, 5HT1a agonist | MicroSource World Drugs |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP00825n | NIH Clinical Collection via PubChem |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP00825n | NIH Clinical Collection via PubChem |
biological_use | Used for the treatment of dysuria associated with benign prostatic hypertrophy | IBScreen Bioactives |
mechanism | Vasodilator | IBScreen Bioactives |
biological_use | Vasodilator, mediates contraction of prostatic smooth muscle | IBScreen Bioactives |
mechanism | Vasodilator | ZereneX Building Blocks |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ADA1A-3-E | Alpha-1a Adrenergic Receptor (cluster #3 Of 3), Eukaryotic | Eukaryotes | 4 | 0.41 | Binding ≤ 10μM |
ADA2A-1-E | Alpha-2a Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 1600 | 0.28 | Binding ≤ 10μM |
ADA2B-3-E | Alpha-2b Adrenergic Receptor (cluster #3 Of 4), Eukaryotic | Eukaryotes | 1600 | 0.28 | Binding ≤ 10μM |
ADA2C-1-E | Alpha-2c Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 1600 | 0.28 | Binding ≤ 10μM |
ADRB2-1-E | Beta-2 Adrenergic Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1000 | 0.29 | Binding ≤ 10μM |
Z104304-1-O | Adrenergic Receptor Alpha-1 (cluster #1 Of 3), Other | Other | 39 | 0.36 | Binding ≤ 10μM |
Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 10000 | 0.24 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
Z104304 | Z104304 | Adrenergic Receptor Alpha-1 | 39 | 0.36 | Binding ≤ 1μM |
ADA1A_HUMAN | P35348 | Alpha-1a Adrenergic Receptor, Human | 3.7 | 0.41 | Binding ≤ 1μM |
ADRB2_CANFA | P54833 | Beta-2 Adrenergic Receptor, Canine | 1000 | 0.29 | Binding ≤ 1μM |
Z104304 | Z104304 | Adrenergic Receptor Alpha-1 | 39 | 0.36 | Binding ≤ 10μM |
ADA1A_HUMAN | P35348 | Alpha-1a Adrenergic Receptor, Human | 3.7 | 0.41 | Binding ≤ 10μM |
ADA2A_RAT | P22909 | Alpha-2a Adrenergic Receptor, Rat | 1600 | 0.28 | Binding ≤ 10μM |
ADA2B_RAT | P19328 | Alpha-2b Adrenergic Receptor, Rat | 1600 | 0.28 | Binding ≤ 10μM |
ADA2C_RAT | P22086 | Alpha-2c Adrenergic Receptor, Rat | 1600 | 0.28 | Binding ≤ 10μM |
ADRB2_CANFA | P54833 | Beta-2 Adrenergic Receptor, Canine | 1000 | 0.29 | Binding ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 10000 | 0.24 | Functional ≤ 10μM |
Description | Species |
---|---|
Adrenaline signalling through Alpha-2 adrenergic receptor | |
Adrenaline,noradrenaline inhibits insulin secretion | |
Adrenoceptors | |
G alpha (12/13) signalling events | |
G alpha (i) signalling events | |
G alpha (q) signalling events | |
G alpha (z) signalling events |